adenosine diphosphate has been researched along with Local Neoplasm Recurrence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arenare, L; Baldassarre, G; Bartoletti, M; Califano, D; Capoluongo, E; Chiodini, P; Costi, MP; D'Incalci, M; Greggi, S; Marchini, S; Mezzanzanica, D; Musacchio, L; Normanno, N; Perrone, F; Pignata, S; Scala, S; Schettino, C | 1 |
| Bao, F; Dai, KS; Ge, XX; Ke, XY; Yan, R; Yang, MN; Ye, HL; Yuan, LX | 1 |
| Aryal, N; Asher, R; Berton, D; Colombo, N; Freimund, AE; Frenel, JS; Huzarski, T; Kim, JW; Korach, J; Ledermann, JA; Lee, CK; Oza, AM; Park-Simon, TW; Pautier, P; Penson, RT; Pignata, S; Pujade-Lauraine, E; Sonke, GS; Tamura, K; Vidal, L | 1 |
| Moore, KN; Washington, CR | 1 |
| Benedetti Panici, P; Di Donato, V; Fischetti, M; Giancotti, A; Monti, M; Musacchio, L; Muzii, L; Palaia, I; Perniola, G; Petrella, MC; Santangelo, G; Tomao, F | 1 |
| Wang, Y; Yin, L; Yu, J; Zhang, L; Zhi, X; Zhou, P | 1 |
2 review(s) available for adenosine diphosphate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse.
Topics: Adenosine Diphosphate; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Ribose | 2022 |
Targeting cervical cancer: Is there a role for poly (ADP-ribose) polymerase inhibition?
Topics: Adenosine Diphosphate; Antineoplastic Agents; Female; Humans; Neoplasm Recurrence, Local; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Uterine Cervical Neoplasms | 2020 |
1 trial(s) available for adenosine diphosphate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
Topics: Adenosine Diphosphate; Antineoplastic Agents; BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Disease Progression; Female; Humans; Maintenance Chemotherapy; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Ribose | 2022 |
3 other study(ies) available for adenosine diphosphate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.
Topics: Adenosine Diphosphate; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Humans; Mangifera; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phthalazines; Piperazines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Ribose | 2022 |
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; B7-H1 Antigen; Biomarkers, Tumor; Blood Platelets; Fibrinogen; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Platelet Adhesiveness; Prognosis; Programmed Cell Death 1 Receptor; Thrombin | 2022 |
Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Topics: 5'-Nucleotidase; Adenocarcinoma, Mucinous; Adenosine Diphosphate; Adult; Aged; Apoptosis; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Carcinoma, Medullary; Cell Adhesion; Cell Movement; Cell Proliferation; Electrophoretic Mobility Shift Assay; ErbB Receptors; Female; GPI-Linked Proteins; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Phosphorylation; Prognosis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Tumor Cells, Cultured | 2012 |